General form of registration statement for all companies including face-amount certificate companies

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES        
Net loss $ (9,353,706) $ (16,128,012) $ (19,390,132) $ (12,096,864)
Adjustments to reconcile net loss to net cash flows used in operating activities:        
Allowance for doubtful accounts       (7,914)
Amortization of right of use assets     (81,659)  
Accreted interest     224,582  
Loss on disposal of fixed assets     183,431  
Loss on conversion of debt       31,943
Change in fair value of derivative liability       975,902
Changes in operating assets and liabilities:        
Depreciation 74,079 102,085 143,459 54,946
Amortization of debt discount and deferred financing costs 481,916 209,056 119,105 835,849
Amortization of intangible assets 13,152 742 1,055 194
Change in fair value of derivative liability 136,323      
Disposal of license 33,334      
Non-cash lease expense 206,161 38,867    
Impairment of operating lease   259,926 292,095  
Impairment of deferred offering and financing costs   270,632 82,332  
Stock-based compensation 3,047,970 912,876 938,052  
Accounts receivable (523,573) (44,726) 10,228 9,329
Inventory (120,799) (75,417) (79,591) (174,624)
Other current assets (205,992) (185,494) (167,192) (477,937)
Accounts payable 701,825 1,642,113 1,210,269 (44,359)
Operating lease liability (357,860) (279,009)    
Deferred revenue (69,632) (11,424)    
Accrued expenses and other current liabilities 1,061,665 1,954,301 1,849,581 2,376,272
Net cash flows used in operating activities (4,875,137) (11,333,484) (14,664,385) (8,517,263)
Deposits     (2,775) (31,965)
Patent costs (27,915) (63,208) (74,111) (53,482)
Purchase of equipment (8,598) (72,030) (77,936) (544,236)
Proceeds from sub-lease deposit 19,332      
Security deposit 3,575 (6,625)    
Purchase of licenses   (200,000) (200,000)  
Net cash flows used in investing activities (13,606) (341,863) (354,822) (629,683)
Proceeds from convertible notes payable       100,000
Proceeds from sale of preferred stock, net of costs 4,217,969      
Repayment of advances from related party       (155,645)
Proceeds from paycheck protection program loan 666,091      
Purchase and retirement of common stock       (3,260)
Proceeds from secured promissory note   10,000,000 10,000,000 9,875,000
Proceeds from sale of common stock, net of costs   5,268,332 6,109,722 4,696
Payment of deferred offering costs   (67,350) (67,350)  
Net cash flows provided by financing activities 4,884,060 15,200,982 16,042,372 9,820,791
Increase decrease in cash, cash equivalents and restricted cash (4,683) 3,525,635 1,023,165 673,845
Effect of foreign currency translation of cash   (5,180)    
Cash and cash equivalent, beginning of year 2,153,028 1,129,863 1,129,863 456,018
Cash, cash equivalents and restricted cash, end of period 2,148,345 4,650,318    
Cash and cash equivalents, end of year 2,129,013   2,153,028 1,129,863
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:        
Cash paid for interest 11,939 921,605 1,038,246 979,167
Cash paid for income taxes
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:        
Forgiveness of accrued officers’ salary 150,002      
Debt exchanged for preferred stock 265,779      
Accrued interest converted to debt 1,254,236 230,565    
Shares issue for extension of debt $ 390,000      
Debt exchanged for common stock   $ 14,496,871 14,496,871  
Accrued interest converted to debt     $ 230,565 17,310
Increase in debt for non cash interest       135,246
Derivative liability       $ 1,141,995